Sunday, April 20, 2025

Yearly Archives: 2020

CHMP recommends approval of Plavix® with aspirin in adults for certain types of strokes

December 11, 2020: "The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an additional indication...

AZ to acquire Alexion, accelerating the Company’s strategic and financial development

December 12,2020: "AstraZeneca and Alexion Pharmaceuticals, Inc. (Alexion) have entered into a definitive agreement for AstraZeneca to acquire Alexion. Alexion shareholders will receive $60 in...

Enhertu scores ‘impressive’ new data in HER2-positive metastatic breast cancer

December 10, 2020: "Updated results from the positive DESTINY-Breast01 Phase II trial showed AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) continued to...

FDA set to review GSK’s Nucala for nasal polyps for chronic rhinosinusitis

December 08, 2020: "GlaxoSmithKline announced that the US FDA has accepted a regulatory submission seeking approval for the use of its anti-IL5 biologic Nucala...

Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics

October 10, 2016: "Crescendo Biologics Limited (Crescendo) announced a global, strategic, multi-target collaboration and license agreement for the discovery, development and commercialization of Humabody® -based therapeutics...

Gilead Announces Racial Equity Community Impact Fund to Support Black Communities Across U.S.

December 09, 2020: "Gilead Sciences announced the launch of its Racial Equity Community Impact Fund, which will support high-impact organizations working to tackle racial...

AZ’s Calquence shows long-term efficacy and tolerability in MCL

December 07, 2020: "A pooled analysis of cardiovascular (CV) safety data from 762 patients treated with Calquence (acalabrutinib) monotherapy for chronic lymphocytic leukaemia (CLL), the most...

Novartis analyses confirm benefit of Kymriah® for advanced lymphomas

December 05, 2020: Novartis announced analyses from two separate trials with Kymriah® (tisagenlecleucel) in patients with certain advanced lymphomas. In the interim analysis of the...

FDA Authorizes First COVID-19 and Flu Combination Test for use with home-collected samples

December 04, 2020: "The U.S. Food and Drug Administration authorized the first diagnostic test for at home collection of patient samples to detect both...

Global equitable access to COVID-19 vaccines estimated to generate economic benefits of at least US$ 153 billion in 2020–21

Global equitable access to COVID-19 vaccines estimated to generate economic benefits of at least US$ 153 billion in 2020–21, and US$ 466 billion by...

Genentech Announces FDA Approval of Xolair for Adults with Nasal Polyps

December 1, 2020: Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental...

Bayer establishes Cell and Gene Therapy Platform

December 2, 2020: Bayer AG announced the launch of a Cell and Gene Therapy (C&GT) Platform within its Pharmaceuticals division. Through this strategic platform,...
- Advertisment -

Most Read